An Exceptional Case of Atrial Fibrillation Arrhythmia Induced by Etoposide

Title:An Exceptional Case of Atrial Fibrillation Arrhythmia Induced by Etoposide

Volume: 8 Issue: 4

Author(s): Wala Ben Kridis, Afef Khanfir, Faten Triki and Mounir Frikha

Affiliation:

Keywords: Atrial fibrillation, cardiotoxicity, chemotherapy, diagnosis, etoposide, prognosis.

Abstract: Background: Arrhythmia induced by etoposide is exceedingly rare. There are only a very few individual case histories of arrhythmias during etoposide infusion, including atrial fibrillation. Objective: Through this uncommon case, we propose to study the pathophysiology, the diagnosis and the management of this entity.

Case Report: We report a case of a 57-year-old man, without cardiac history, followed for endocrine tumor of the pancreas with liver metastases who had presented atrial fibrillation (AF) after etoposide infusion.

Conclusion: It is important to consider cardiac monitoring during etoposide infusion in patients with known cardiac disease or at high risk of cardiac complications.

Cite this article as:

Kridis Ben Wala, Khanfir Afef, Triki Faten and Frikha Mounir, An Exceptional Case of Atrial Fibrillation Arrhythmia Induced by Etoposide, Current Drug Safety 2013; 8(4) . https://dx.doi.org/10.2174/15748863113080990047